Molecular Epidemiology of Programmed Cell Death 1-Ligand 1 (PD-L1) Protein Expression in Non-Small Cell Lung Cancer

被引：0
|
作者：
Schabath, Matthew [1 ]
Dalvi, Tapashi [2 ]
Dai, Hongyue [3 ]
Crim, Alan [3 ]
Midha, Anita [4 ]
Shire, Norah [2 ]
Walker, Jill
Greenawalt, Danielle [5 ]
Lawrence, David
Rigas, James [6 ]
Brody, Robert [2 ]
Potter, Danielle [2 ]
Kumar, Naveen [3 ]
Huntsman, Shane [3 ]
Grays, Jhanelle [7 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol, Tampa, FL USA
[2] Astrazeneca, Gaithersburg, MD USA
[3] M2Gen, Tampa, FL USA
[4] Astrazeneca, Chester, Cheshire, England
[5] Astrazeneca, Waltham, MA USA
[6] Astrazeneca, Hanover, NH USA
[7] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
PD-L1; lung cancer; epidemiology; Immunotherapy;
D O I：
10.1016/j.jtho.2016.11.566
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.01-042
引用
收藏
页码：S475 / S476
页数：2
相关论文
共 50 条
  • [21] Programmed death-ligand (PD-L1) expression and tissue heterogeneity in advanced non-small cell lung cancer (NSCLC)
    Decatris, Marios
    Hayes, Mark
    Du Rand, Ingrid
    Ryan, Philip
    Phillips, Aled
    El-Batrawy, Sherouk
    Homewood, Renate
    Thomas, Joy
    Bowden, Caitlin
    Taniere, Phillipe
    LUNG CANCER, 2021, 156 : S29 - S30
  • [22] Programmed death ligand 1 (PD-L1) expression status as prognostic factor in early stage non-small cell lung cancer (NSCLC)
    D'Arcangelo, M.
    Puccetti, M.
    Bravaccini, S.
    D'Incecco, A.
    Ligorio, C.
    Terracciano, L.
    Damiani, S.
    Bennati, C.
    Minuti, G.
    Vecchiarelli, S.
    Landi, L.
    Incarbone, M.
    Milesi, M.
    Ravaioli, S.
    Tumedei, M. M.
    Rossi, E.
    Cappuzzo, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [23] Association Between Programmed Death Ligand-1 (PD-L1) Expression and Clinicopathological Features in Non-small Cell Lung Cancer (NSCLC)
    Valcarcel Gonzalez, S.
    Diaz, P.
    Villanueva Palicio, N.
    Alvarez Fernandez, C.
    Contreras Toledo, D. C.
    Mihic Gongora, L.
    Rodriguez Gonzalez, A.
    Velasco Durantez, V.
    Solis Hernandez, M. D. P.
    Esteban Gonzalez, E.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S569 - S570
  • [24] PD-L1 Expression and Molecular Alterations in Non-Small Cell Lung Cancer
    Ebare, K.
    Song, W.
    Opitz, L.
    Rosca, O.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (03): : S52 - S53
  • [25] Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancer
    Lamberti, G.
    Spurr, L. F.
    Li, Y.
    Ricciuti, B.
    Recondo, G.
    Umeton, R.
    Nishino, M.
    Sholl, L. M.
    Meyerson, M. L.
    Cherniack, A. D.
    Awad, M. M.
    ANNALS OF ONCOLOGY, 2020, 31 (06) : 807 - 814
  • [26] Prevalence of programmed cell death ligand 1 (PD-L1) Expression among Tumor Samples from Iraqi Patients with Non-Small Cell Lung Cancer
    Yahya, Alaa Qasim
    Alhamadani, Zina A. Rajab
    Ahmed, Samir Z.
    Hussain, Ahmad Fawzi
    ADVANCEMENTS IN LIFE SCIENCES, 2025, 12 (01): : 114 - 119
  • [27] Programmed Cell Death Ligand 1 Expression in Resected Non-Small Cell Lung Cancer
    Yu, Hui
    Brustugun, Odd Terje
    Ekman, Simon
    Botling, Johan
    La Fleur, Linnea
    Micke, Patrick
    Solberg, Steinar
    Berglund, Anders
    Rivard, Christopher
    Hirsch, Fred R.
    CLINICAL LUNG CANCER, 2021, 22 (04) : E555 - E562
  • [28] Programmed death ligand-1 expression in non-small cell lung cancer
    Velcheti, Vamsidhar
    Schalper, Kurt A.
    Carvajal, Daniel E.
    Anagnostou, Valsamo K.
    Syrigos, Konstantinos N.
    Sznol, Mario
    Herbst, Roy S.
    Gettinger, Scott N.
    Chen, Lieping
    Rimm, David L.
    LABORATORY INVESTIGATION, 2014, 94 (01) : 107 - 116
  • [29] Compare the efficacy and safety of programmed cell death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) inhibitors for advanced non-small cell lung cancer: a Bayesian analysis
    Liang, Jiaqi
    Li, Ming
    Sui, Qihai
    Hu, Zhengyang
    Bian, Yunyi
    Huang, Yiwei
    Zhan, Cheng
    Jiang, Wei
    Wang, Qun
    Tan, Lijie
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (04) : 1302 - +
  • [30] Evaluation of Programmed Death Ligand 1 (PD-L1) Gene Amplification and Response to Nivolumab Monotherapy in Non-small Cell Lung Cancer
    Inoue, Yusuke
    Yoshimura, Katsuhiro
    Nishimoto, Koji
    Inui, Naoki
    Karayama, Masato
    Yasui, Hideki
    Hozumi, Hironao
    Suzuki, Yuzo
    Furuhashi, Kazuki
    Fujisawa, Tomoyuki
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Asada, Kazuhiro
    Uto, Tomohiro
    Fujii, Masato
    Matsui, Takashi
    Matsuura, Shun
    Hashimoto, Dai
    Toyoshima, Mikio
    Kusagaya, Hideki
    Matsuda, Hiroyuki
    Inami, Nao
    Kaida, Yusuke
    Niwa, Mitsuru
    Ito, Yasuhiro
    Sugimura, Haruhiko
    Suda, Takafumi
    JAMA NETWORK OPEN, 2020, 3 (09) : E2011818
12345